We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.91B
AUM Growth
+$545M
Cap. Flow
+$210M
Cap. Flow %
5.36%
Top 10 Hldgs %
40.38%
Holding
2,228
New
603
Increased
482
Reduced
356
Closed
557

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$84.4M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$81.5M
3
VAL icon
Valaris
VAL
+$24.1M
4
CAI
CAI International, Inc.
CAI
+$12.6M
5
STMP
Stamps.com, Inc.
STMP
+$11M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$22.9M
2
PRAH
PRA Health Sciences, Inc.
PRAH
+$19.4M
3
PFPT
Proofpoint, Inc.
PFPT
+$19M
4
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$16.1M
5
MXIM
Maxim Integrated Products
MXIM
+$15.5M

Sector Composition

Rank Sector Weight
1 Financials 9.4%
2 Technology 6.32%
3 Consumer Discretionary 5.14%
4 Industrials 4.27%
5 Communication Services 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTGC icon
1376
PUT
Hercules Capital
HTGC
$3.21B
$166K ﹤0.01%
+10,000
New +$170K
JBI icon
1377
Janus International
JBI
$732M
$166K ﹤0.01%
13,531
-117,921
-90% -$1.61M
GSQD.U
1378
DELISTED
G Squared Ascend I Inc. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant to acquire one Class A ordinary share
GSQD.U
$166K ﹤0.01%
+16,459
New +$164K
TOON icon
1379
Kartoon Studios
TOON
$35.3M
$164K ﹤0.01%
12,076
-220
-2% -$3.42K
GFX.U
1380
DELISTED
Golden Falcon Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
GFX.U
$164K ﹤0.01%
+16,354
New +$165K
EPIX
1381
DELISTED
ESSA Pharma
EPIX
$163K ﹤0.01%
+20,351
New +$324K
FTVI
1382
DELISTED
FinTech Acquisition Corp. VI Class A Common Stock
FTVI
$163K ﹤0.01%
+16,700
New +$163K
OTRK
1383
DELISTED
Ontrak
OTRK
$161K ﹤0.01%
+178
New +$318K
OTRK
1384
PUT
DELISTED
Ontrak
OTRK
$161K ﹤0.01%
+178
New +$318K
PBR icon
1385
Petrobras
PBR
$118B
$161K ﹤0.01%
15,613
-14,227
-48% -$152K
ENZ
1386
DELISTED
Enzo Biochem, Inc.
ENZ
$161K ﹤0.01%
45,500
– –
NMMC
1387
DELISTED
North Mountain Merger Corp. Class A Common Stock
NMMC
$161K ﹤0.01%
+15,915
New +$155K
YEXT icon
1388
Yext
YEXT
$577M
$160K ﹤0.01%
13,300
-60,393
-82% -$778K
CLBR.U
1389
DELISTED
Colombier Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
CLBR.U
$158K ﹤0.01%
+15,979
New +$158K
LEGA
1390
DELISTED
Lead Edge Growth Opportunities, Ltd Class A Ordinary Shares
LEGA
$158K ﹤0.01%
+15,910
New +$155K
SBII
1391
DELISTED
Sandbridge X2 Corp.
SBII
$157K ﹤0.01%
16,044
+6,044
+60% +$58.7K
INNV icon
1392
InnovAge Holding
INNV
$1.48B
$156K ﹤0.01%
+23,600
New +$365K
SLAMW
1393
DELISTED
Slam Corp. warrant
SLAMW
$156K ﹤0.01%
173,366
– –
NORW
1394
DELISTED
Global X MSCI Norway ETF
NORW
$156K ﹤0.01%
+10,800
New +$154K
JUGGW
1395
DELISTED
Jaws Juggernaut Acquisition Corporation Warrant
JUGGW
$155K ﹤0.01%
+130,225
New +$153K
RFP
1396
DELISTED
Resolute Forest Products Inc.
RFP
$155K ﹤0.01%
13,000
– –
DILAU
1397
DELISTED
DILA Capital Acquisition Corp. Unit
DILAU
$153K ﹤0.01%
15,000
– –
GGPI
1398
CALL
DELISTED
Gores Guggenheim, Inc. Class A Common Stock
GGPI
$153K ﹤0.01%
+15,000
New +$149K
COCH icon
1399
Envoy Medical
COCH
$54.3M
$152K ﹤0.01%
15,629
– –
KYNB
1400
Kyntra Bio
KYNB
$28.2M
$152K ﹤0.01%
596
+144
+32% +$51K
54 55
56
57 58

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Prelude Capital Management held 2,228 positions worth $3.91B, up 16% from $3.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management deployed $210M of net new capital in Q3 2021, opening 603 new positions and adding to 482 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Frontier Communications, an estimated $8.65M trimmed.

  • Prelude Capital Management's largest Q3 2021 buy was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
  • Prelude Capital Management added most to Valaris in Q3 2021, an estimated $24.1M increase.
  • Prelude Capital Management's biggest Q3 2021 reduction was Frontier Communications, cutting an estimated $8.65M.
  • Prelude Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.9M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $3.91B portfolio in Q3 2021.
  • Prelude Capital Management opened 603 new positions and closed 557 in Q3 2021.
  • Prelude Capital Management's portfolio value rose 16% quarter-over-quarter to $3.91B.

Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.